Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
CureVac AG, a pioneering biopharmaceutical company headquartered in Tübingen, Germany, is at the forefront of mRNA technology. Founded in 2000, CureVac has made significant strides in the development of innovative therapies and vaccines, particularly in the fields of oncology and infectious diseases.
The company is renowned for its proprietary mRNA platform, which enables the creation of targeted treatments that harness the body’s own immune response. Notable achievements include the advancement of its COVID-19 vaccine candidate, which showcased the potential of mRNA in rapid vaccine development.
With a strong market position and collaborations with leading pharmaceutical companies, CureVac AG continues to drive advancements in the biotechnology sector, aiming to transform the landscape of medicine through its unique approach to mRNA therapeutics.
23
DitchCarbon score
-19 vs industry average
Curevac AG’s score of 23 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Curevac AG?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Curevac AG yet.
Curevac AG's reported carbon emissions
Curevac AG, headquartered in Germany, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of CureVac N.V., which may influence its climate reporting and commitments.
Curevac AG has not established any documented reduction targets or specific climate pledges at this time. The absence of data suggests that the company may still be in the process of developing its climate strategy or reporting framework.
As a part of the biopharmaceutical industry, Curevac AG is positioned within a sector that is increasingly focusing on sustainability and carbon reduction. While no specific emissions data or targets are available, the company’s affiliation with CureVac N.V. may provide opportunities for alignment with broader corporate sustainability initiatives.
In summary, while Curevac AG has not disclosed specific emissions data or reduction commitments, its corporate structure may play a role in shaping its future climate strategies.
Assessing Curevac AG as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Curevac AG and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Curevac AG’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Curevac AG yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
Inherited from CureVac N.V.See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Curevac AG1 year ago
23
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more